The EU Commission has extended the State Aid Temporary Framework to enable acceleration of R&D, testing and production of COVID-19 relevant products.
On 3 April, the EU Commission has extended the State Aid Temporary Framework adopted on 19 March 2020 to enable Member States to accelerate the research, testing and production of coronavirus relevant products, to protect jobs and to further support the economy in the context of the COVID-19 outbreak. The extension, currently in place until the end of December 2020, provides for five additional types of aid measures:
(i) Direct grants, repayable advances or tax advantages for coronavirus related research and development (R&D);
(ii) Direct grants tax advantages, repayable advances and no-loss guarantees for the construction and upscaling of testing facilities;
(iii) Direct grants, tax advantages, repayable advances and no-loss guarantees for the production of products relevant to tackle the coronavirus outbreak.
A bonus may be granted when the investment is supported by more than one Member State and for support measures (ii) and (iii) an additional bonus may be granted when the investment is concluded within two months after the granting of the aid.
(iv) Targeted support in the form of deferral of tax payments and/or suspensions of social security contributions;
(v) Targeted support in the form of wage subsidies for employees.
The amendment further expands on the existing types of support that Member States can give to companies in need including direct grants, zero-interest loans, full risk guarantees on loans, equity and a combination of such with de minimis aid and other aid.
Should you have any queries or wish to discuss further, please send an email to firstname.lastname@example.org.
The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavour to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation.
© 2021 KPMG, a Malta civil partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International, a Swiss cooperative. All rights reserved.
KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.